Resistance to Antimicrobians – A Global Problem with Sectoral Resolution

<abstract xmlns="http://www.w3.org/1999/xhtml">Ventilator-associated pneumonia (VAP) is a common and serious nosocomial infection in mechanically ventilated patients and results in high mortality, prolonged intensive care unit- (ICU) and hospital-length of stay and increased costs. In order to reduce its incidence, it is imperative to better understand the involved mechanisms and to identify the source of infection. The role of the endotracheal tube (ET) in VAP pathogenesis became more prominent over the last decades, along with extensive research dedicated to medical device-related infections and biofilms. ET biofilm formation is an early and constant process in intubated patients. New data regarding its temporal dynamics, composition, germ identification and consequences enhance knowledge about VAP occurrence, microbiology, treatment response and recurrence. This paper presents a structured analysis of the medical literature to date, in order to outline the role of ET biofilm in VAP pathogenesis and to review recommended methods to identify ET biofilm microorganisms and to prevent or decrease VAP incidence.</abstract>

Endotracheal Tube Biofilm and its Impact on the Pathogenesis of Ventilator-Associated Pneumonia

<abstract xmlns="http://www.w3.org/1999/xhtml">A comprehensive analysis of published cases of Takotsubo cardiomyopathy, occurred in liver transplant recipients in the perioperative period, has been attempted in this review. Predisposing factors, precipitating events, potential physiological mechanisms, acute and post-event management have been discussed.</abstract>

Perioperative Stress-Induced (Takotsubo) Cardiomyopathy in Liver Transplant Recipients

<abstract xmlns="http://www.w3.org/1999/xhtml">Although cardiac tumours are uncommon, cardiac myxomas account for more than fifty percent of all cases and are the most frequent primary cardiac tumour. They have a broad clinical spectrum, usually related to cardiac symptoms, peripheral embolic events or systemic manifestations. We present a case report of a 68-year-old man who presented with systemic symptoms and analytical features suggestive of an autoimmune disease. In the ensuing diagnostic procedures, a cardiac myxoma was found, and after surgical resection, both the systemic manifestations and the analytical abnormalities disappeared.</abstract>

Incidental Finding of a Left Atrial Myxoma while Characterising an Autoimmune Disease

<abstract xmlns="http://www.w3.org/1999/xhtml">Introduction Nonbacterial thrombotic endocarditis (NBTE), also known as marantic endocarditis, is a rare, underdiagnosed complication of cancer, in the context of a hypercoagulable state. NBTE represents a serious complication due to the high risk of embolisation from the sterile cardiac vegetations. If these are not properly diagnosed and treated, infarctions in multiple arterial territories may occur. Case presentation The case of a 47-year-old male is described. The patient was diagnosed with a gastric adenocarcinoma, in which the first clinical manifestation was NBTE. Subsequently, a hypercoagulability syndrome was associated with multi-organ infarctions, including stroke and eventually resulted in a fatal outcome. Conclusions NBTE must be considered in patients with multiple arterial infarcts with no cardiovascular risk factors, in the absence of an infectious syndrome and negative blood cultures. Cancer screening must be performed to detect the cause of the prothrombotic state.</abstract>

Severe Fatal Systemic Embolism Due to Non-Bacterial Thrombotic Endocarditis as the Initial Manifestation of Gastric Adenocarcinoma: Case Report

AHEAD OF PRINT

Volume 9 (2023): Issue 4 (October 2023)

Volume 9 (2023): Issue 3 (July 2023)

Volume 9 (2023): Issue 2 (April 2023)

Volume 9 (2023): Issue 1 (January 2023)

Volume 8 (2022): Issue 4 (October 2022)

Volume 8 (2022): Issue 3 (July 2022)

Volume 8 (2022): Issue 2 (April 2022)

Volume 8 (2022): Issue 1 (January 2022)

Volume 7 (2021): Issue 4 (October 2021)

Volume 7 (2021): Issue 3 (July 2021)

Volume 7 (2021): Issue 2 (April 2021)

Volume 7 (2021): Issue 1 (January 2021)

Volume 6 (2020): Issue 4 (October 2020)

Volume 6 (2020): Issue 3 (July 2020)

Volume 6 (2020): Issue 2 (April 2020)

Volume 6 (2020): Issue 1 (January 2020)

Volume 5 (2019): Issue 4 (October 2019)

Volume 5 (2019): Issue 3 (July 2019)

Volume 5 (2019): Issue 2 (April 2019)

Volume 5 (2019): Issue 1 (January 2019)

Volume 4 (2018): Issue 4 (October 2018)

Volume 4 (2018): Issue 3 (July 2018)

Volume 4 (2018): Issue 2 (April 2018)

Volume 4 (2018): Issue 1 (January 2018)

Volume 3 (2017): Issue 4 (October 2017)

Volume 3 (2017): Issue 3 (July 2017)

Volume 3 (2017): Issue 2 (April 2017)

Volume 3 (2017): Issue 1 (February 2017)

Volume 2 (2016): Issue 4 (October 2016)

Volume 2 (2016): Issue 3 (July 2016)

Volume 2 (2016): Issue 2 (April 2016)

Volume 2 (2016): Issue 1 (January 2016)

Volume 1 (2015): Issue 4 (October 2015)

Volume 1 (2015): Issue 3 (July 2015)

Volume 1 (2015): Issue 2 (April 2015)

Volume 1 (2015): Issue 1 (January 2015)

The Journal of Critical Care Medicine

The Journal of Critical Care Medicine aims to publish high quality double-blind peer-reviewed articles integrating a broad range of topics from the entire spectrum of Critical CareMedicine and related pathologies of critical care patients, including, but not restricted to general surgery, perioperative care, cardiology, internal medicine, pneumology, infectious diseases, organ transplantation, emergency medicine, pediatrics and neurology. Our journal’s scope is to provide for intensivists all around the world the newest information related to the critical ill patients, treatments and their outcomes.  The journal will consider for publication suitable articles offering new insights into pathophysiological mechanisms, diagnostic and treatment in critical care medicine, from basic to clinical academic research, including also relevant topics on biomedical research, health policy research, medical technology development and ethical concerns.  Publication fee  The publication fee for an accepted article is 250 EUR.  Why subscribe and read  The journal addresses the entire community of specialists involved in treating the critically illpatients, with a special focus on the scientific community from Central and Eastern European countries, aiming to provide studies on critical care medicine with a new regional perspective, specific for this part of Europe but not restricted to it. The journal will also publish international, overseas articles that would discuss current topics in peri-operative and critical care medicine, contributing to a better understanding of the pathologies leading to critical illnesses and reflecting international models of care for these conditions.  Why submit  The journal will stimulate publication of research that could be easily translated into clinical practice. The diversity of published articles, from "letter to editor" to most complex scientific research, will ensure various possibilities for knowledge dissemination. We encourage the use of open-access instrument ORCID ID for authors, which is also used by reviewers, and editorial board members. New accounts can be created manually or by retrieve the details from the ORCID registry   Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 